{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:20:59Z","timestamp":1791105659483,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","award":["11565"],"award-info":[{"award-number":["11565"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1006\/exnr.2001.7647","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T11:46:56Z","timestamp":1032176816000},"page":"122-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Coadministration of (\u2212)-OSU6162 with  -DOPA Normalizes Preproenkephalin mRNA Expression in the Sensorimotor Striatum of Primates with Unilateral 6-OHDA Lesions"],"prefix":"10.1006","volume":"169","author":[{"given":"Walter","family":"Pirker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Tedroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Pont\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per E.","family":"Andr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin L.","family":"Hurd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.2001.7647_RF1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.2001.7647_RF2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: Neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.2001.7647_RF3","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1471-4159.1990.tb04887.x","article-title":"Effect of chronic typical and atypical neuroleptic treatment on proenkephalin mRNA levels in the striatum and nucleus accumbens of the rat","author":"Angulo","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2001.7647_RF4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0173(94)90002-7","article-title":"Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens","volume":"19","author":"Angulo","year":"1994","journal-title":"Brain Res. Rev."},{"key":"10.1006\/exnr.2001.7647_RF5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/brain\/115.3.825","article-title":"Behavioural analysis of unilateral monoamine depletion in the marmoset","volume":"115","author":"Annett","year":"1992","journal-title":"Brain"},{"key":"10.1006\/exnr.2001.7647_RF6","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00001756-199410270-00037","article-title":"Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys","volume":"5","author":"Asselin","year":"1994","journal-title":"NeuroReport"},{"key":"10.1006\/exnr.2001.7647_RF7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0169-328X(89)90032-6","article-title":"Cellular localization of enkephalin gene expression in MPTP-treated cynomolgus monkeys","volume":"6","author":"Augood","year":"1989","journal-title":"Mol. Brain Res."},{"key":"10.1006\/exnr.2001.7647_RF8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0169-328X(94)90226-7","article-title":"Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat","volume":"23","author":"Bronstein","year":"1994","journal-title":"Mol. Brain Res."},{"key":"10.1006\/exnr.2001.7647_RF9","first-page":"41","article-title":"Opioid peptide precursor expression in animal models of dystonia secondary to dopamine-replacement therapy in Parkinson's disease","volume":"78","author":"Brotchie","year":"1998","journal-title":"Adv. Neurol."},{"key":"10.1006\/exnr.2001.7647_RF10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0306-4522(93)90062-K","article-title":"Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: Differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels","volume":"57","author":"Cenci","year":"1993","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2001.7647_RF11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.870050203","article-title":"A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment","volume":"5","author":"Crossman","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.2001.7647_RF12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.2001.7647_RF13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/exnr.1997.6431","article-title":"Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression","volume":"144","author":"Duty","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2001.7647_RF14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/exnr.1997.6771","article-title":"Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat","volume":"150","author":"Duty","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2001.7647_RF15","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1097\/00001756-199707280-00029","article-title":"(\u2212)-OSU6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease","volume":"8","author":"Ekesbo","year":"1997","journal-title":"NeuroReport"},{"key":"10.1006\/exnr.2001.7647_RF16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.52.1.120","article-title":"Dopamine autoreceptor function is lost in advanced Parkinson's disease","volume":"52","author":"Ekesbo","year":"1999","journal-title":"Neurology"},{"key":"10.1006\/exnr.2001.7647_RF17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(92)90716-M","article-title":"Dopaminergic modulation of striatal neuropeptides: Differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin","volume":"581","author":"Engber","year":"1992","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2001.7647_RF18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-8993(91)90667-K","article-title":"Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats","volume":"553","author":"Engber","year":"1991","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2001.7647_RF19","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1212\/WNL.47.6_Suppl_3.184S","article-title":"Is levodopa toxic?","volume":"47","author":"Fahn","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/exnr.2001.7647_RF20","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: Substantia nigra regional selectivity","volume":"114","author":"Fearnly","year":"1991","journal-title":"Brain"},{"key":"10.1006\/exnr.2001.7647_RF21","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1006\/exnr.2001.7647_RF22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1523\/JNEUROSCI.11-04-01016.1991","article-title":"Dopamine differentially regulates dynorphin, substance P and enkephalin expression in striatal neurons: In situ hybridization histochemistry analysis","volume":"11","author":"Gerfen","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.2001.7647_RF23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00002512-199609030-00001","article-title":"Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's disease","volume":"9","author":"Henry","year":"1996","journal-title":"Drugs Aging"},{"key":"10.1006\/exnr.2001.7647_RF24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1998.6996","article-title":"Effect of repeated l-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat","volume":"155","author":"Henry","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2001.7647_RF25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0306-4522(95)00120-8","article-title":"Effects of l-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum","volume":"68","author":"Herrero","year":"1995","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2001.7647_RF26","first-page":"253","article-title":"Parkinsonism treated with levodopa: Progression and mortality","author":"Hoehn","year":"1983","journal-title":"J. Neural Transm."},{"key":"10.1006\/exnr.2001.7647_RF27","first-page":"223","article-title":"Effects of long-term administration of antipsychotic drugs on enkephalinergic neurons","volume":"24","author":"Hong","year":"1980","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"10.1006\/exnr.2001.7647_RF28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/306611a0","article-title":"Isolation and structural organization of the human preproenkephalin B gene","volume":"306","author":"Horikawa","year":"1983","journal-title":"Nature"},{"key":"10.1006\/exnr.2001.7647_RF29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0306-4522(96)00002-4","article-title":"Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain","volume":"72","author":"Hurd","year":"1996","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2001.7647_RF30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0169-328X(95)00084-6","article-title":"l-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP","volume":"32","author":"Jolkkonen","year":"1995","journal-title":"Mol. Brain Res."},{"key":"10.1006\/exnr.2001.7647_RF31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/syn.890090304","article-title":"Distribution of cocaine recognition sites in monkey brain. I. In vitro autoradiography with [3H]CFT","volume":"9","author":"Kaufman","year":"1991","journal-title":"Synapse"},{"key":"10.1006\/exnr.2001.7647_RF32","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1073\/pnas.88.10.4205","article-title":"Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene","volume":"88","author":"Le Moine","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.2001.7647_RF33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1073\/pnas.87.1.230","article-title":"Dopamine receptor gene expression by enkephalin neurons in rat forebrain","volume":"87","author":"Le Moine","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.2001.7647_RF34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0169-328X(90)90020-E","article-title":"Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum","volume":"8","author":"Li","year":"1990","journal-title":"Mol. Brain Res."},{"key":"10.1006\/exnr.2001.7647_RF35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/exnr.1994.1007","article-title":"On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus","volume":"125","author":"Maneuf","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2001.7647_RF36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0169-328X(97)00123-X","article-title":"Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: Comparison with l-DOPA therapy","volume":"49","author":"Morissette","year":"1997","journal-title":"Mol. Brain Res."},{"key":"10.1006\/exnr.2001.7647_RF37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1471-4159.1999.0720682.x","article-title":"Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists","volume":"72","author":"Morissette","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2001.7647_RF38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02896851","article-title":"Localization of striatal opioid gene expression, and its modulation by the mesostriatal dopamine pathways: An in situ hybridization study","volume":"1","author":"Morris","year":"1989","journal-title":"J. Mol. Neurosci."},{"key":"10.1006\/exnr.2001.7647_RF39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0969-8051(97)00023-1","article-title":"Synthesis of [11C-methyl]-(\u2212)-OSU6162, its regional brain distribution and some pharmacological effects of (\u2212)-OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomography","volume":"24","author":"Neu","year":"1997","journal-title":"Nuclear Med. Biol."},{"key":"10.1006\/exnr.2001.7647_RF40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/297431a0","article-title":"Isolation and structural organization of the human preproenkephalin gene","volume":"297","author":"Noda","year":"1982","journal-title":"Nature"},{"key":"10.1006\/exnr.2001.7647_RF41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0006-8993(88)91459-X","article-title":"Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons","volume":"439","author":"Normand","year":"1988","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2001.7647_RF42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/WNL.40.2.340","article-title":"Levodopa-induced dyskinesia: Review, observations, and speculations","volume":"40","author":"Nutt","year":"1990","journal-title":"Neurology"},{"key":"10.1006\/exnr.2001.7647_RF43","first-page":"73","article-title":"Dopaminergic regulation of peptide gene expression in the striatum of normal and parkinsonian monkeys","volume":"69","author":"Parent","year":"1996","journal-title":"Adv. Neurol."},{"key":"10.1006\/exnr.2001.7647_RF44","first-page":"9","article-title":"l-Dopa and dyskinesias in normal monkeys","volume":"14","author":"Pearce","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.2001.7647_RF45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0169-328X(92)90092-P","article-title":"Differential dopaminergic regulation of proenkephalin and prodynorphin mRNAs in the basal ganglia of rats","volume":"12","author":"Reimer","year":"1992","journal-title":"Mol. Brain Res."},{"key":"10.1006\/exnr.2001.7647_RF46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0169-328X(97)00068-5","article-title":"Differential regional effects of long-term l-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat","volume":"47","author":"Salin","year":"1997","journal-title":"Mol. Brain Res."},{"key":"10.1006\/exnr.2001.7647_RF47","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1523\/JNEUROSCI.19-15-06643.1999","article-title":"Striatal preproenkephalin gene expression is upregulated in acute but not chronic Parkinsonian monkeys: Implications for the contribution of the indirect striatopallidal circuit to Parkinsonian symptomatology","volume":"19","author":"Schneider","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.2001.7647_RF48","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/jm00043a013","article-title":"Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure\u2013activity relationships","volume":"37","author":"Sonesson","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1006\/exnr.2001.7647_RF48A","series-title":"The Brain of the Common Marmoset (Callitrix Jacchus)","author":"Stephan","year":"1980"},{"key":"10.1006\/exnr.2001.7647_RF49","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1098-2396(199804)28:4<280::AID-SYN3>3.0.CO;2-5","article-title":"Effects of the substituted (S)-3-phenylpiperidine (\u2212)-OSU6162 on PET measurements in subhuman primates: Evidence for tone-dependent normalization of striatal dopaminergic activity","volume":"28","author":"Tedroff","year":"1998","journal-title":"Synapse"},{"key":"10.1006\/exnr.2001.7647_RF50","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1460-9568.1994.tb00291.x","article-title":"Rostrocaudal subregional differences in the response of enkephalin, dynorphin and substance P synthesis in the rat nucleus accumbens to dopamine depletion","volume":"6","author":"Voorn","year":"1994","journal-title":"Eur. J. Neurosci."},{"key":"10.1006\/exnr.2001.7647_RF51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0006-8993(87)91149-8","article-title":"Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions","volume":"412","author":"Voorn","year":"1987","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2001.7647_RF52","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1073\/pnas.83.24.9827","article-title":"Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain","volume":"83","author":"Young","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.2001.7647_RF53","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1460-9568.2000.00988.x","article-title":"Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with l-DOPA","volume":"12","author":"Zeng","year":"2000","journal-title":"Eur. J. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488601976472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488601976472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:38:48Z","timestamp":1762148328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488601976472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S0014488601976472"],"URL":"https:\/\/doi.org\/10.1006\/exnr.2001.7647","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coadministration of (\u2212)-OSU6162 with -DOPA Normalizes Preproenkephalin mRNA Expression in the Sensorimotor Striatum of Primates with Unilateral 6-OHDA Lesions","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/exnr.2001.7647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}